211 related articles for article (PubMed ID: 10562927)
1. [Usefulness of photoplethysmography and indexes of digital pressure in Raynaud phenomenon].
Martínez S; Lozano P; Pallarés L; Juliá J; Artigues I; Plaza A; Rimbau EM; Corominas C; Gómez FT
Med Clin (Barc); 1999 Sep; 113(9):327-30. PubMed ID: 10562927
[TBL] [Abstract][Full Text] [Related]
2. [Validity of plethysmography and the digital temperature recovery test in the diagnosis of primary and occupational Raynaud's phenomenon].
Laroche GP; Thériault G
Clin Invest Med; 1987 Mar; 10(2):96-102. PubMed ID: 3581549
[TBL] [Abstract][Full Text] [Related]
3. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
5. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
Bounameaux HM; Hellemans H; Verhaege R
Int Angiol; 1986; 5(1):39-44. PubMed ID: 3734514
[TBL] [Abstract][Full Text] [Related]
6. [Calcium antagonists for the treatment of Raynaud's phenomenon].
Müller-Bühl U; Diehm C; Scheuermann W; Mörl H
Dtsch Med Wochenschr; 1983 Nov; 108(47):1795-7. PubMed ID: 6357692
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of digital venous reactivity to cold by plethysmographic measurement of compliance to cold and hot. Application of the method to 80 patients with Raynaud's phenomena and 36 controls].
Planchon B; de Faucal P; Grolleau JY
J Mal Vasc; 1986; 11(1):80-4. PubMed ID: 3944526
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide dinitrate ointment in Raynaud's disease.
Diehm C; Müller-Bühl U; Mörl H
Z Kardiol; 1983; 72 Suppl 3():185-7. PubMed ID: 6364591
[TBL] [Abstract][Full Text] [Related]
9. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
[TBL] [Abstract][Full Text] [Related]
10. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonic dopplerography and photoplethysmography in the diagnosis of Raynaud's syndrome].
Druzhinin SO
Revmatologiia (Mosk); 1989; (4):54-7. PubMed ID: 2700238
[TBL] [Abstract][Full Text] [Related]
12. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
[TBL] [Abstract][Full Text] [Related]
13. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
Pistorius MA; Planchon B; de Faucal P
Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
[TBL] [Abstract][Full Text] [Related]
14. [Video-thoracoscopic sympathectomy in the treatment of Raynaud's disease and palmar hyperhidrosis].
Trignano M; Boatto R; Mastino GP; Ferrandu T; Padula G; Loi V; Pala C
Minerva Chir; 2000; 55(1-2):17-23. PubMed ID: 10832279
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's phenomenon in arterial occlusive disease.
Tordoir JH; Winterkamp H; Dekkers W
Neth J Surg; 1985 Aug; 37(4):97-100. PubMed ID: 4047443
[TBL] [Abstract][Full Text] [Related]
16. [Hemodynamic response of the digital artery to heat and cold in normal subjects, in systemic scleroderma and in Raynaud's disease].
Vayssairat M; Mathieu JF; Housset E
J Mal Vasc; 1984; 9(1):7-10. PubMed ID: 6707534
[TBL] [Abstract][Full Text] [Related]
17. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
Rhedda A; McCans J; Willan AR; Ford PM
J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
[TBL] [Abstract][Full Text] [Related]
18. Slow release nifedipine in the treatment of Raynaud's phenomenon.
Costantini A; Martelli E; Bavera P; Agus GB
Int Angiol; 1987; 6(4):359-63. PubMed ID: 3330116
[TBL] [Abstract][Full Text] [Related]
19. Raynaud's phenomenon.
O'connor CM
J Vasc Nurs; 2001 Sep; 19(3):87-92; quiz 93-4. PubMed ID: 11533581
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
Fries R; Shariat K; von Wilmowsky H; Böhm M
Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
